Rome, Italy

Giovanni DiStazio


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giovanni DiStazio: Innovator in Pharmaceutical Applications

Introduction

Giovanni DiStazio is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development efforts. His work focuses on the use of specific compounds to address various health conditions.

Latest Patents

Giovanni holds a patent for the "Use of 3-indolepyruvic acid as a pharmaceutical agent for the inhibition." This patent highlights the compound's inhibitory activity against the degenerative effects caused by oxygen free radicals. These free radicals are known to contribute to numerous pathological conditions in various peripheral tissues. The applications of this compound are promising, particularly in treating miocardiopathies, inflammations, circulatory shock, arteriosclerosis, and cardiac ischemia.

Career Highlights

Giovanni DiStazio has established himself as a key figure in the pharmaceutical industry. His work at Polifarma S.p.a. has allowed him to explore and develop innovative solutions that can significantly impact patient care. His dedication to research and development has led to advancements in the understanding and treatment of various medical conditions.

Collaborations

Giovanni has collaborated with esteemed colleagues such as Vincenzo Politi and Giovanna DeLuca. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Giovanni DiStazio's contributions to the pharmaceutical field through his patent and collaborative efforts exemplify the importance of innovation in medicine. His work continues to pave the way for new treatments that can improve health outcomes for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…